Murine MHC class II H2-E binds Influenza H19 head distinct from the sialic acid binding site but sterically conflicts with TCR binding
Receptor recognition by influenza A virus (IAV) hemagglutinin (HA) is a key determinant of viral entry and host range, traditionally-known to be mediated by sialylated glycans. Previous studies have suggested that major histocompatibility complex class II (MHC II), the antigen-presenting molecule recognized by CD4⁺ T cells, can serve as an entry receptor for several IAVs. The molecular basis of this alternative receptor recognition and its potential implications for MHC II-associated immune functions remain incompletely understood. Here, we report that in vitro expressed H19 bound murine H2-E (I-E), whereas H17 and MHC II from other species tested showed no detectable binding, and a 2.65 Å cryo-electron microscopy structure of the H19/H2-E complex was determined. The H2-E α1 domain binds the lateral surface of the HA head outside the canonical sialic acid-binding pocket, forming three contact regions without directly contacting the peptide presented by H2-E. The key residue candidates within the interaction interface indicate the species-dependent recognition of murine and mallard compared to other species. We also observed two or three H2-E bound to a single H19 trimer, but with limited particle numbers. The structure of two H2-E with one H19 trimer was solved to 6.06 Å and an apo H19 structure was also solved here to 2.67 Å. Structural superposition suggested steric incompatibility of the H19 docking with T cell receptor or HLA-DM binding configurations. These findings define the molecular architecture of H19/MHC II complex recognition and suggest a potential link between influenza receptor usage and MHC II-associated immune functions.
Authors
- Baihan Huang
- 张艳芳
- Chengyu Liu (ORCID: https://orcid.org/0000-0002-1771-729X)
- Haichen Wang (ORCID: https://orcid.org/0000-0003-0352-630X)
- Chenyang Huang (ORCID: https://orcid.org/0000-0003-2408-4483)
- Yuxin Chen (ORCID: https://orcid.org/0000-0001-5170-5797)
- Yeerzhati Tuluhongtayi
- Xinwen Chen
- Linjie Li
- Qile Wu
- Wang Changliang
- George Fu Gao
- Qiyu Liang
- Jun Liu
- Jincun Zhao
- Qiuyang Li
- Chao Lv
- Yuhang Gu
- Jing Chen
- Yingze Zhao
- Xinyu Zhao
- Jingjing Sheng
- Yutong Zhai
- Hao Qu
- Jianing Zhang
- Hao Song
- Zeyu Zhang
Institutions
- Shandong University (CN)
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- Chinese Center For Disease Control and Prevention (CN)
- Chinese Academy of Sciences (CN)
- University of Macau (MO)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Wuhan Institute of Virology (CN)
- Nanjing Drum Tower Hospital (CN)
- Institute of Microbiology (CN)
- National Institute for Viral Disease Control and Prevention (CN)
- Beijing Ditan Hospital (CN)
- State Key Laboratory of Respiratory Disease (CN)
- University of Chinese Academy of Sciences (CN)
- State Key Laboratory of Pharmaceutical Biotechnology (CN)
- State Key Laboratory of Virology (CN)
- Guangzhou Laboratory (CN)
- Guangzhou Institute of Respiratory Health (CN)
- Nanjing University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Published
- 2026-11-21
- DOI
- https://doi.org/10.65215/ltspreprints.2026.11.20.000395
- Primary Topic
- Influenza Virus Research Studies
- Type
- preprint
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China